POET Technologies Inc. ('POET' or the 'Company') (NASDAQ: POET), a leader in highly integrated optical engines and light ...
AX-0810 target engagement data in healthy volunteers on track for Q2 2026; biliary atresia selected as initial Phase 2 indicationPipeline expansion with advancement of AX-0811 (NTCP) and AX-0422 (IDUA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results